Literature DB >> 26504416

Endoscopic stent placement in the management of malignant colonic obstruction: Experiences from two centers.

Bünyamin Gürbulak1, Esin Kabul Gürbulak2, İsmail Ethem Akgün2, Kenan Büyükaşık1, Hasan Bektaş1.   

Abstract

OBJECTIVE: Intestinal obstruction due to colorectal tumors requires immediate surgical decompression. Endoscopic stent placement for acute malignant colonic obstruction is gaining widespread acceptance as an alternative to emergency surgery. Our aim in this study was to evaluate the success and complication rates of endoscopic stenting for malignant colonic obstruction.
MATERIAL AND METHODS: Patients with acute malignant colonic obstruction who underwent endoscopic stenting between 2011-2014 were retrospectively reviewed. Data included demographic features, localization of obstruction, endoscopic stenting indications, rate of technical and clinical success, complications, morbidity and mortality.
RESULTS: Endoscopic stent was successfully placed in 77 out of 82 procedures (93.9%). A colostomy was placed in five cases in which endoscopic stent could not be inserted. There were complications in seven patients with technically successful stents (9.0%). These included three stent migrations, one perforation, and rectal hemorrhage in three patients. There were no stent-related deaths.
CONCLUSION: The mortality rate of emergency surgery for malignant bowel obstruction is relatively high. The use of colonic stents can avoid surgery in patients who are not suitable for emergency surgery and may allow adequate time for preoperative preparation, counseling and staging for those who are suitable for further intervention. We believe that self-expandable metallic stent placement is a safe, effective, and minimal invasive alternative treatment method for malignant colonic obstruction.

Entities:  

Keywords:  Colorectal carcinoma; malignant intestinal obstruction; self-expandable colonic stent

Year:  2015        PMID: 26504416      PMCID: PMC4605108          DOI: 10.5152/UCD.2015.2828

Source DB:  PubMed          Journal:  Ulus Cerrahi Derg        ISSN: 1300-0705


  16 in total

Review 1.  Self-expandable metal stents in palliation of malignant gastrointestinal obstruction: review of the current literature data and 5-year experience at Harbor-UCLA Medical Center.

Authors:  Sofiya Gukovsky-Reicher; Richard M Lin; Shahid Sial; Benedict Garrett; Dennis Wu; Tonny Lee; Hanson Lee; Tracey Arnell; Michael J Stamos; Victor E Eysselein
Journal:  MedGenMed       Date:  2003-01-10

2.  Practice parameters for colon cancer.

Authors:  Daniel Otchy; Neil H Hyman; Clifford Simmang; Thomas Anthony; W Donald Buie; Peter Cataldo; James Church; Jeffrey Cohen; Frederick Dentsman; C Neal Ellis; John W Kilkenny; Clifford Ko; Richard Moore; Charles Orsay; Ronald Place; Janice Rafferty; Jan Rakinic; Paul Savoca; Joe Tjandra; Mark Whiteford
Journal:  Dis Colon Rectum       Date:  2004-08       Impact factor: 4.585

3.  Colorectal stenting for colonic obstruction: the indications, complications, effectiveness and outcome--5 year review.

Authors:  S Athreya; J Moss; G Urquhart; R Edwards; A Downie; F W Poon
Journal:  Eur J Radiol       Date:  2006-06-27       Impact factor: 3.528

4.  Emergency management of acute obstructed left-sided colon cancer: loops, stents or tubes?

Authors:  K Søreide
Journal:  Endoscopy       Date:  2013-03-26       Impact factor: 10.093

5.  Colonic stent vs. emergency surgery for management of acute left-sided malignant colonic obstruction: a decision analysis.

Authors:  Laura E Targownik; Brennan M Spiegel; Jonathan Sack; Oscar J Hines; Gareth S Dulai; Ian M Gralnek; James J Farrell
Journal:  Gastrointest Endosc       Date:  2004-12       Impact factor: 9.427

6.  Post-metallic stent placement bleeding caused by stent-induced ulcers.

Authors:  Chun-Tao Wai; Christopher Khor; Siew-Eng Lim; Khek-Yu Ho
Journal:  World J Gastroenterol       Date:  2005-09-28       Impact factor: 5.742

7.  Acute colorectal obstruction: treatment with self-expandable metallic stents before scheduled surgery--results of a multicenter study.

Authors:  A Mainar; M A De Gregorio Ariza; E Tejero; R Tobío; E Alfonso; I Pinto; M Herrera; J A Fernández
Journal:  Radiology       Date:  1999-01       Impact factor: 11.105

8.  Hematogenous tumor cell dissemination during colonoscopy for colorectal cancer.

Authors:  M Koch; P Kienle; P Sauer; F Willeke; K Buhl; A Benner; T Lehnert; C Herfarth; M von Knebel Doeberitz; J Weitz
Journal:  Surg Endosc       Date:  2004-01-23       Impact factor: 4.584

Review 9.  Systematic review of the efficacy and safety of colorectal stents.

Authors:  U P Khot; A Wenk Lang; K Murali; M C Parker
Journal:  Br J Surg       Date:  2002-09       Impact factor: 6.939

10.  Effect of bowel obstruction on stage IV colorectal cancer.

Authors:  Wei Chen; Xiao-Ping Tan; Jun-Wen Ye; Qin Liu; Qingli Zeng; Lei Wang; Jian-Ping Wang
Journal:  Mol Clin Oncol       Date:  2014-01-10
View more
  3 in total

1.  Colonoscopic perforations: Single center experience and review of the literature.

Authors:  Şükrü Çolak; Bünyamin Gürbulak; Hasan Bektaş; Ekrem Çakar; Yiğit Düzköylü; Savaş Bayrak; Ayhan Güneyi
Journal:  Turk J Surg       Date:  2017-04-25

2.  Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update.

Authors:  Andrew M Veitch; Franco Radaelli; Raza Alikhan; Jean-Marc Dumonceau; Diane Eaton; Jo Jerrome; Will Lester; David Nylander; Mo Thoufeeq; Geoffroy Vanbiervliet; James R Wilkinson; Jeanin E van Hooft
Journal:  Endoscopy       Date:  2021-08-06       Impact factor: 10.093

3.  Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update.

Authors:  Andrew M Veitch; Franco Radaelli; Raza Alikhan; Jean Marc Dumonceau; Diane Eaton; Jo Jerrome; Will Lester; David Nylander; Mo Thoufeeq; Geoffroy Vanbiervliet; James R Wilkinson; Jeanin E Van Hooft
Journal:  Gut       Date:  2021-09       Impact factor: 23.059

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.